Low bone mineral density, regardless of HIV status, in men who have sex with men

Journal of Infectious Diseases

Volumn 207, Issue 3, 2013, Pages 386-391

  Grijsen, Marlous L ^a   Vrouenraets, Saskia M E ^b   Wit, Ferdinand W N M ^b   Stolte, Ineke G ^c   Prins, Maria ^c   Lips, Paul ^d   Reiss, Peter ^a,b   Prins, Jan M ^a  

^a Center for Infection and Immunity Amsterdam   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone mineral density; chronic HIV infection; HIV negative controls; men who have sex with men; primary HIV infection

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; PHOSPHATE; PROCOLLAGEN; PROCOLLAGEN TYPE 1 N TERMINAL PROPEPTIDE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG; VIRUS RNA; BIOCHEMICAL MARKER;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; TESTOSTERONE BLOOD LEVEL; VITAMIN BLOOD LEVEL; HIP; LUMBAR SPINE; MEN WHO HAVE SEX WITH MEN; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE DENSITY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 84872032881     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis687     Document Type: Article

References (15)

1. McComsey GA, Tebas P, Shane E, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 2010; 51:937-46.
2. Grijsen ML, Vrouenraets SM, Steingrover R, et al. High prevalence of reduced bone mineral density in primary HIV-1-infected men. Aids 2010; 24:2233-8.
3. Grijsen ML, Steingrover R, Wit FW, et al. No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized primo-SHM trial. PLoS Med 2012; 9:e1001196.
4. van Griensven GJ, de Vroome EM, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ 1989; 298:218-21.
5. Foundation NO. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation, 2010.
6. Hileman CO, Labbato DE, Storer NJ, McComsey GA. Bone mineral density, vitamin D levels and inflammation markers in antiretroviralnaive HIV-infected and uninfected adults [abstract 93]. Presented at: 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 5-8 March 2012.
7. Liu AY, Vittinghoff E, Sellmeyer DE, et al. Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One 2011; 6: e23688.
8. Mulligan K, Glidden D, Gonzales P, et al. Effects of FTC/TDF on bone mineral density in seronegative men from 4 continents: DEXA results of the global iPrEx study [abstract 94LB]. Presented at: 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 27 February 27-2 March 2011.
9. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. Aids 2006; 20:2165-74.
10. Health of lesbian, gay, bisexual, and transgender populations. Lancet 2011; 377:1211.
11. Bolland MJ, Grey AB, Gamble GD, Reid IR. CLINICAL Review : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab 2007; 92:4522-8.
12. Stall R, Paul JP, Greenwood G, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men's Health Study. Addiction 2001; 96:1589-601.
13. Schett G, David JP. The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol 2010; 6:698-706.
14. Pietschmann P, Muller C, Woloszczuk W. Serum osteocalcin levels are decreased in patients with acute viral hepatitis. Bone Miner 1991; 13:251-6.
15. Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344:1979-84.